ArticleCureus2026
Breast Cancer and Beyond: Screening, Psychosocial, and Socioeconomic Dimensions of Patient Experience During Radiotherapy in a United Arab Emirates Cohort.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Breast cancer care extends beyond tumor-directed treatment to include screening behavior, psychosocial well-being, body image, family support, and financial and logistical burden. These issues are particularly relevant during radiotherapy, where repeated hospital attendance may amplify practical and emotional stressors. This study described multidimensional patient-experience domains among women receiving breast cancer care through the radiotherapy pathway at a tertiary cancer center in the United Arab Emirates. Methods A descriptive cross-sectional survey was conducted among 30 women with breast cancer managed through the radiation oncology pathway at SEHA Tawam Hospital, Al Ain, UAE, between August 12 and October 8, 2024. A structured bilingual questionnaire in Arabic and English was administered by tablet or QR code. Variables included demographic characteristics, screening participation, cancer detection pathway, lifestyle factors, financial concerns, perceived stress before and after diagnosis, body image, family support, and interest in supportive-care interventions. Descriptive statistics were used. Results The mean age at diagnosis among respondents with numeric age data was 47.4 years (SD 11.9; range 27-70; n=29). Most questionnaires were completed in Arabic (24/30, 80.0%) and by tablet (27/30, 90.0%). Most participants were married (17/30, 56.7%), 13 (43.3%) resided in Al Ain, and 20 (66.7%) were unemployed. Only 12 participants (40.0%) reported prior participation in a breast screening program, while 21 (70.0%) reported self-detection of a breast lump as the detection pathway. Physical activity of less than 30 minutes per day was reported by 17 participants (56.7%). Mean perceived stress increased from 5.3/10 before diagnosis to 6.9/10 after diagnosis. Mean scores also indicated high family/friend support (8.3/10), body image impact (6.0/10), support-group interest (5.4/10), financial impact (5.0/10), financial worry (5.2/10), and medical expense concern (4.7/10). Conclusions In this small single-center UAE cohort, women receiving breast cancer care through the radiotherapy pathway reported low screening participation, frequent self-detection, increased stress after diagnosis, body-image concerns, financial/logistical burdens, and interest in supportive-care interventions. These findings support integrating structured psychosocial assessment, screening outreach, and supportive-care pathways into breast radiotherapy services.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.